Abstract
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have